AGP Executive Report
Last update: 9 hours agoVaccine Research: Guinea-Bissau has cancelled a US-funded hepatitis B trial planned for 14,000 newborns after critics warned it would delay a WHO-recommended vaccine for half the babies. The government said the study lacked required approval, and police seized vaccine supplies from the research centre. Energy Access: A regional electricity project continues despite political tensions, bringing improved service to nearly half a million people across Mali, The Gambia and Guinea-Bissau and connecting 490 communities.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.